NVCR News and Press, NovoCure Limited From 10/13/20

Valuations for stocks such as Datadog (DDOG), DraftKings (DKNG), NovoCure (NVCR), and Chegg (CHGG) look stretched. The company's current and expected financials fail to justify their valuations. Its best to avoid these stocks for the remainder of this year. The S&P 500 has gained appr...

Novocure (NASDAQ: NVCR) announced today that it will report financial results for the third quarter 2020 on Thursday, October 29, 2020, before the U.S. financial markets open. Novocure’s management will host a conference call and webcast to discuss its financial results for the t...

Novocure’s virtual Research & Development Day on November 12 will highlight progress across clinical and developmental pipelines and introduce areas of focus in translational research Novocure (NASDAQ: NVCR) announced today that it will host a virtual Research &am...

Unfortunately, glioblastoma is an aggressive brain tumor that still remains difficult to treat. To this day, there is still an unmet need for treatment, with only 8.7% of patients surviving for up to two years, according to Tactical Therapeutics. However, it appears some companies are making ...

In a year dominated by the Covid crisis and the search for a treatment/vaccine, the last week has seen progress in the fight against cancer, and helped send the biotech sector surging. More news on: Gilead Sciences, Inc., Merck & Co., Inc., Immunomedics, Inc., , News on ETFs Read mo...

Novocure (NASDAQ: NVCR) announced today that William Doyle, the company’s Executive Chairman, and Dr. Uri Weinberg, the company’s Chief Science Officer, will participate in the 2020 Wells Fargo Virtual Healthcare Conference on September 9, 2020. Mr. Doyle and Dr. Weinberg will t...

The stock market has a way of surprising and our overbought indicator suggests investors banking on uninterrupted gains could be disappointed. Weekly, we track how many of the 1,500 widely-traded stocks in our marketplace universe are trading 5% or higher above their 200-day moving average. ...

Wilco Groenhuysen appointed to an expanded Chief Operating Officer role Ashley Cordova promoted to Chief Financial Officer Frank Leonard promoted to Chief Development Officer Novocure (NASDAQ:NVCR) today announced an expansion of its Executive Leadership Team, effective Sept....

Image source: The Motley Fool. NovoCure   (NASDAQ: NVCR) Q2 2020 Earnings Call Jul 30, 2020 , 8:00 a.m. ET Operator Continue reading

NovoCure Limited (NVCR) Q2 2020 Results Conference Call July 30, 2020 08:00 AM ET Company Participants Ashley Cordova - Senior Vice President of Finance & Investor Relations Bill Doyle - Executive Chairman Asaf Danziger - Chief Executive Officer Wilco Groenhuysen - Chief Fi...